Pulmonx Corp (LUNG)

$6.26 -0.14 (-2.19%)
Market Cap 252.72M
Revenue (ttm) 68.68M
Net Income (ttm) -60.84M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -88.58%
Debt to Equity Ratio 0.40
Volume 140,200
Avg Vol 233,162
Day's Range N/A - N/A
Shares Out 39.49M
Stochastic %K 47%
Beta 0.66
Analysts Strong Sell
Price Target $11.58

Latest News on LUNG

Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference

Nov 20, 2024, 4:05 PM EST - 2 months ago

Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference

Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers

Nov 19, 2024, 9:00 AM EST - 2 months ago

Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers

Pulmonx to Present at the Stifel 2024 Healthcare Conference

Nov 5, 2024, 4:05 PM EST - 2 months ago

Pulmonx to Present at the Stifel 2024 Healthcare Conference

Pulmonx Corporation (LUNG) Q3 2024 Earnings Call Transcript

Oct 31, 2024, 6:54 AM EDT - 2 months ago

Pulmonx Corporation (LUNG) Q3 2024 Earnings Call Transcript

Pulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024

Oct 16, 2024, 4:05 PM EDT - 3 months ago

Pulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024

Pulmonx Announces Presentation of Clinical Data from the AeriSeal® CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024

Sep 9, 2024, 4:05 PM EDT - 4 months ago

Pulmonx Announces Presentation of Clinical Data from the AeriSeal® CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024

Pulmonx to Participate in the Lake Street 8th Annual Best Ideas Growth Conference

Aug 29, 2024, 4:05 PM EDT - 5 months ago

Pulmonx to Participate in the Lake Street 8th Annual Best Ideas Growth Conference

Pulmonx to Present at the 2024 Wells Fargo Healthcare Conference

Aug 22, 2024, 4:05 PM EDT - 5 months ago

Pulmonx to Present at the 2024 Wells Fargo Healthcare Conference

Pulmonx Corporation (LUNG) Q2 2024 Earnings Call Transcript

Jul 31, 2024, 10:33 PM EDT - 6 months ago

Pulmonx Corporation (LUNG) Q2 2024 Earnings Call Transcript

Pulmonx Reports Second Quarter 2024 Financial Results

Jul 31, 2024, 4:05 PM EDT - 6 months ago

Pulmonx Reports Second Quarter 2024 Financial Results

Pulmonx to Present at the Canaccord Genuity 44th Annual Growth Conference

Jul 29, 2024, 4:05 PM EDT - 6 months ago

Pulmonx to Present at the Canaccord Genuity 44th Annual Growth Conference

Pulmonx: Low Bar For Q2 Earnings

Jul 21, 2024, 9:00 AM EDT - 6 months ago

Pulmonx: Low Bar For Q2 Earnings

Pulmonx to Report Second Quarter 2024 Financial Results on July 31, 2024

Jul 10, 2024, 4:05 PM EDT - 6 months ago

Pulmonx to Report Second Quarter 2024 Financial Results on July 31, 2024

Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

May 6, 2024, 5:03 PM EDT - 9 months ago

Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Pulmonx Corporation (LUNG) Q1 2024 Earnings Call Transcript

May 1, 2024, 9:08 PM EDT - 9 months ago

Pulmonx Corporation (LUNG) Q1 2024 Earnings Call Transcript

Pulmonx Reports First Quarter 2024 Financial Results

May 1, 2024, 4:05 PM EDT - 9 months ago

Pulmonx Reports First Quarter 2024 Financial Results

Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024

Apr 10, 2024, 4:05 PM EDT - 10 months ago

Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024

Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer

Apr 2, 2024, 4:05 PM EDT - 10 months ago

Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer

Pulmonx Announces Treatment of the First Patient with the AeriSeal® System in CONVERT II Pivotal Trial

Feb 26, 2024, 8:00 AM EST - 11 months ago

Pulmonx Announces Treatment of the First Patient with the AeriSeal® System in CONVERT II Pivotal Trial

Pulmonx Corporation (LUNG) Q4 2023 Earnings Call Transcript

Feb 21, 2024, 9:01 PM EST - 11 months ago

Pulmonx Corporation (LUNG) Q4 2023 Earnings Call Transcript

Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results

Feb 21, 2024, 4:06 PM EST - 11 months ago

Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results

Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer

Feb 21, 2024, 4:05 PM EST - 11 months ago

Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer

Pulmonx to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024

Feb 7, 2024, 4:05 PM EST - 1 year ago

Pulmonx to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024

Pulmonx to Present at the Piper Sandler 35th Annual Healthcare Conference

Nov 15, 2023, 4:05 PM EST - 1 year ago

Pulmonx to Present at the Piper Sandler 35th Annual Healthcare Conference

The Prognosis For Pulmonx Corporation

Nov 8, 2023, 12:01 PM EST - 1 year ago

The Prognosis For Pulmonx Corporation

Pulmonx to Participate at Upcoming Investor Conferences

Oct 31, 2023, 4:05 PM EDT - 1 year ago

Pulmonx to Participate at Upcoming Investor Conferences

Pulmonx Corporation (LUNG) Q3 2023 Earnings Call Transcript

Oct 30, 2023, 8:37 PM EDT - 1 year ago

Pulmonx Corporation (LUNG) Q3 2023 Earnings Call Transcript

Pulmonx Reports Record Third Quarter 2023 Financial Results

Oct 30, 2023, 4:05 PM EDT - 1 year ago

Pulmonx Reports Record Third Quarter 2023 Financial Results

Pulmonx to Report Third Quarter 2023 Financial Results on October 30, 2023

Oct 16, 2023, 4:05 PM EDT - 1 year ago

Pulmonx to Report Third Quarter 2023 Financial Results on October 30, 2023

Pulmonx Announces CFO Transition and Record Preliminary Third Quarter 2023 Revenue

Oct 10, 2023, 4:05 PM EDT - 1 year ago

Pulmonx Announces CFO Transition and Record Preliminary Third Quarter 2023 Revenue

Pulmonx Corporation (LUNG) Q2 2023 Earnings Call Transcript

Aug 6, 2023, 2:20 AM EDT - 1 year ago

Pulmonx Corporation (LUNG) Q2 2023 Earnings Call Transcript

Pulmonx Reports Second Quarter 2023 Financial Results

Aug 2, 2023, 4:05 PM EDT - 1 year ago

Pulmonx Reports Second Quarter 2023 Financial Results

Pulmonx to Present at the Canaccord Genuity 43rd Annual Growth Conference

Jul 26, 2023, 4:05 PM EDT - 1 year ago

Pulmonx to Present at the Canaccord Genuity 43rd Annual Growth Conference

Pulmonx to Report Second Quarter 2023 Financial Results on August 2, 2023

Jul 17, 2023, 8:00 AM EDT - 1 year ago

Pulmonx to Report Second Quarter 2023 Financial Results on August 2, 2023

Pulmonx: Entry To Japan Market Bullish For Zephyr Volumes (Rating Upgrade)

Jun 23, 2023, 8:52 AM EDT - 1 year ago

Pulmonx: Entry To Japan Market Bullish For Zephyr Volumes (Rating Upgrade)

Pulmonx Corporation (LUNG) Q1 2023 Earnings Call Transcript

May 2, 2023, 11:55 PM EDT - 1 year ago

Pulmonx Corporation (LUNG) Q1 2023 Earnings Call Transcript

Pulmonx Reports First Quarter 2023 Financial Results

May 2, 2023, 4:05 PM EDT - 1 year ago

Pulmonx Reports First Quarter 2023 Financial Results

Pulmonx to Present at the Bank of America Securities 2023 Health Care Conference

Apr 25, 2023, 4:05 PM EDT - 1 year ago

Pulmonx to Present at the Bank of America Securities 2023 Health Care Conference

Pulmonx to Report First Quarter 2023 Financial Results on May 2, 2023

Apr 18, 2023, 4:05 PM EDT - 1 year ago

Pulmonx to Report First Quarter 2023 Financial Results on May 2, 2023

Pulmonx Corporation (LUNG) Q4 2022 Earnings Call Transcript

Feb 22, 2023, 9:48 PM EST - 2 years ago

Pulmonx Corporation (LUNG) Q4 2022 Earnings Call Transcript

Pulmonx Reports Fourth Quarter and Full Year 2022 Financial Results

Feb 22, 2023, 4:05 PM EST - 2 years ago

Pulmonx Reports Fourth Quarter and Full Year 2022 Financial Results

Pulmonx to Present at the Citi 2023 Healthcare Conference

Feb 16, 2023, 4:05 PM EST - 2 years ago

Pulmonx to Present at the Citi 2023 Healthcare Conference

Pulmonx to Report Fourth Quarter and Full Year 2022 Financial Results on February 22, 2023

Feb 8, 2023, 4:05 PM EST - 2 years ago

Pulmonx to Report Fourth Quarter and Full Year 2022 Financial Results on February 22, 2023

American Lung Association Campaign Shines Spotlight on Endobronchial Valves for Advanced COPD/Emphysema

Dec 14, 2022, 4:05 PM EST - 2 years ago

American Lung Association Campaign Shines Spotlight on Endobronchial Valves for Advanced COPD/Emphysema

Pulmonx Receives Japanese MHLW Approval of Zephyr Endobronchial Valve for the Treatment of Severe COPD/Emphysema

Nov 30, 2022, 7:00 AM EST - 2 years ago

Pulmonx Receives Japanese MHLW Approval of Zephyr Endobronchial Valve for the Treatment of Severe COPD/Emphysema

Pulmonx to Present at the 34th Annual Piper Sandler Healthcare Conference

Nov 16, 2022, 4:05 PM EST - 2 years ago

Pulmonx to Present at the 34th Annual Piper Sandler Healthcare Conference

Pulmonx: An Ideal Takeout Candidate

Nov 10, 2022, 2:29 AM EST - 2 years ago

Pulmonx: An Ideal Takeout Candidate

Pulmonx Corporation (LUNG) Q3 2022 Earnings Call Transcript

Nov 6, 2022, 12:03 PM EST - 2 years ago

Pulmonx Corporation (LUNG) Q3 2022 Earnings Call Transcript

Pulmonx to Report Third Quarter 2022 Financial Results on November 3, 2022

Oct 20, 2022, 4:05 PM EDT - 2 years ago

Pulmonx to Report Third Quarter 2022 Financial Results on November 3, 2022

ADDING and REPLACING CONVERT Clinical Trial Data Presented at ERS Demonstrates Early Success of AeriSeal System in Patients with Advanced COPD/Emphysema

Sep 9, 2022, 3:29 PM EDT - 2 years ago

ADDING and REPLACING CONVERT Clinical Trial Data Presented at ERS Demonstrates Early Success of AeriSeal System in Patients with Advanced COPD/Emphysema